HANNAH HEUSING: Open Payments
NPI 1487252367 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 60 payments from 19 companies in 2025. Trend: 2023 $1,949 · 2024 $1,287 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $264 |
| Otsuka America Pharmaceutical, Inc. | 10 | $190 |
| Neurocrine BioSciences, Inc. | 5 | $126 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
| Alkermes, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 4 | $65 |
| Noven Therapeutics, LLC | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $39 |
Products named: CAPLYTA, REXULTI, INGREZZA, SPRAVATO, HETLIOZ, Xelstrym, UZEDY, VRAYLAR.
Industry payments across SC — which companies pay providers there.
